http://life1nvest.blogspot.my/2016/11/elsoft-201613.html

1. 从7月1日至10月6日止，Elsoft到手的合约订单预估为RM32,000K。
2. 今年第三季度订单与去年同期不相伯仲(2015第三季营业额 - RM 17,258K,净利润 – RM12,440K,当时美元兑令吉 RM4.44).由于今年第三季美元兑令吉是RM4.11，净利润的外汇收益将受影响。
3. 整体而言，公司下半年估计今年营业额表现会更胜去年。（笔者认为到手合约订单预估为RM32,000K，已经超越2015营业额，更期待10月7号到12月31号希望有更多订单）
4. 槟城蝴蝶公园（Butterfly Farm）- 今年次季仍未摆脱亏损，因为今年5月才重新开张，所以今年第二季仅有1一个月贡献。现在游客明显增加，预料第三季将对蝴蝶公园带来贡献，2016财政年相信会有所改善。(对Elsoft是件好事，如果槟城蝴蝶未来开始有利润，Elsoft可以选择三年后转换去普通股。)
5. Leso延后上市，由于市场疲弱，Leso控股不会在今年上市。公司继续观察以及等待市场转好，再重新探讨上市计划。（对笔者来说有点小失望）
6. 公司在9月28号宣布2送1红股计划，回馈股东，也增加流通量。

Robotsaham Jstock Codings and Tutorials

ONLINE coaching - Group Premium Student Mahersaham

Next Q4/FY17 will be critical for Elsoft...

Day 12 of Fundamental Daily, YAPSS will be covering Elsoft Research Berhad's fundamental via a short animated video. I hope it helps and enjoy the video! #FundamentalDaily012

Click the on the link below to find out more:  
https://www.youtube.com/watch?v=OaHke1ugDIc

YAPSS Quick Summary and Free 10 Years Financial Data of Elsoft Research Berhad:
https://www.yapss.com/forum/klse-forum/elsoft-research-berhad-elsoft-0090
 

On Friday, Elsoft Research Bhd (ELSOFT:KLS) closed at 0.600, 55.84% above the 52 week low of 0.385 set on Mar 19, 2020.

Price rises above 50-day moving average to 0.610

Kajian Saham Picisan

On Tuesday, Elsoft Research Bhd (ELSOFT:KLS) closed at 0.65, 68.83% above the 52 week low of 0.385 set on Mar 19, 2020.

Kajian Saham Picisan

On Wednesday, Elsoft Research Bhd (ELSOFT:KLS) closed at 0.685, 77.92% above the 52 week low of 0.385 set on Mar 19, 2020.

Kajian Saham Picisan

https://www.theedgemarkets.com/article/elsoft-research-may-rise-higher-says-rhb-retail-research-0

Burned Out? Why Elsoft’s Test Equipment Business Needs a Reboot

Once upon a time, Elsoft Research Berhad was riding high, churning out test and burn-in systems like nobody's business. These clever contraptions found eager customers in the booming world of smartphones and shiny gadgets. Life was good.

But then came 2019. Demand for LED flash testing started drying up as smartphone makers got a little too comfortable with “good enough,” and product designs moved on. And just when Elsoft was wondering what else could go wrong, along came COVID-19, slamming the brakes on capex and shipping schedules. Revenue took a nosedive.

In 2021 and 2022, things perked up a bit - thanks to delayed orders finally getting delivered and customers emerging from lockdown hibernation. But this was a short lived rebound. The core smart device segment never came back, and Elsoft’s newer bets - like automotive and medical test equipment - were still warming up on the sidelines.

Today, Elsoft sits in what we’d call the “Quicksand quadrant” in the Fundamental Mapper It is not sinking dramatically, but it is definitely stuck. The company is making all the right noises - more R&D, new markets, a pivot to EVs and medical devices - but real growth is still a work in progress. Until those bets pay off, Elsoft’s story is less “comeback kid” and more “patient in rehab.”